Carson Wealth (CWM LLC)
MLTX icon

Carson Wealth (CWM LLC)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.67K Buy
304
+244
+407% +$4.04K ﹤0.01% 4979
2025
Q4 		$1K Sell
60
-82
-58% -$968 ﹤0.01% 5252
2025
Q3 		$1K Buy
142
+22
+18% +$1.15K ﹤0.01% 5155
2025
Q2 		$6K Buy
120
+71
+145% +$2.89K ﹤0.01% 4545
2025
Q1 		$2K Buy
49
+24
+96% +$1.03K ﹤0.01% 4783
2024
Q4 		$1K Buy
25
+14
+127% +$715 ﹤0.01% 4750
2024
Q3 		$1K Buy
11
+6
+120% +$281 ﹤0.01% 4634
2024
Q2 		$0 Buy
+5
New +$212 ﹤0.01% 4795

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Carson Wealth (CWM LLC)'s MLTX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its MoonLake Immunotherapeutics (MLTX) stake by 407% in Q1 2026, buying an estimated $4.04K and bringing the position to 304 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4979.

Carson Wealth (CWM LLC) first reported a position in MLTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $6K in Q2 2025. 147 funds tracked by Wall St. Rank hold MLTX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 304 shares of MoonLake Immunotherapeutics worth $5.67K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 244 MoonLake Immunotherapeutics shares in Q1 2026, an estimated $4.04K.
  • MoonLake Immunotherapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4979 holding.
  • Carson Wealth (CWM LLC) first reported a position in MoonLake Immunotherapeutics in Q2 2024 and has held it in 8 quarters since.
  • Carson Wealth (CWM LLC)'s MoonLake Immunotherapeutics position peaked at $6K in Q2 2025.
  • 147 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.